Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer

Figure 5

KEGG signaling pathways related to the risk score by GSEA. (a, b) Enriched signaling pathways in the high- and low-risk gastric cancer samples in the training set. (c, d) Enriched signaling pathways in the high- and low-risk gastric cancer samples in the GSE66229 dataset.

(a)

(b)

(c)

(d)